Welcome back to Stockhouse Member Sign In
Sign in with one of the following accounts.
Send my password
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Use one of the following accounts.
REOLYSIN™ gets orphan drug designation from European Medicines Agency for the treatment of pancreatic cancer
Everything you could ever want to know about biotech, biomed and bio investments up north.
only a lil bit
Just yell B R A D !!!!!!!!!!!!!!!!! bloke
It appears from the latest financials that the cash reserves between March 31 to May 6 9 (five weeks)went up by $0.9 million. Who is...
Does Brad suffer from Attention Deficit Disorder? The last two press releases should make investors wonder. Oncolytics Biotech was...